Answers are grounded in this paper and cite their sources.
Background: New York State prohibits cannabis retailers from providing individualized medical advice, including to pregnant or nursing individuals. This study sought to understand cannabis retailer recommendations and practices when interacting with pregnant individuals. Methods: We conducted cross-sectional mystery-shopper calls to all licensed adult-use cannabis retailers in New York State (February-April 2026). Callers posed as pregnant individuals and retailers were randomized to nausea or non-nausea scripts. Outcomes included retailer characterization of the safety of cannabis use during pregnancy, mode-specific recommendations, and referral to a health care professional. Retailer websites were also reviewed for pregnancy-related warning statements. Multinomial logistic regression examined differences in retailer advice by geography and business characteristics (region, Conditional Adult-Use Retail Dispensary status, and pregnancy-related website warnings), using “deferred medical guidance” as the reference category. Results: Among 422 retailers who were called, 3% indicated cannabis use during pregnancy was safe, 51% advised it was unsafe, 12% expressed uncertainty, and 35% deferred medical guidance. Thirty percent suggested differences in safety by mode of use with edibles most endorsed as safer (27%) and smoking most identified as harmful (22%). Over half of retailers (54%) recommended consulting a health care professional without prompting, and 39% did so only after prompting. No significant differences were observed by script assignment. Retailer advice differed significantly by region ( P < .001). Compared with New York City retailers, those in suburban and upstate regions were less likely to state that cannabis use during pregnancy is unsafe (relative to deferring medical guidance), with the strongest difference observed among upstate retailers. Conclusions: Cannabis retailer messaging during pregnancy was variable but largely aligned with regulatory and public health guidance, with most retailers advising against use or deferring medical guidance. A smaller proportion provided inconsistent or unclear recommendations. These findings suggest overall compliance alongside remaining gaps in standardization, highlighting the need for clearer guidance to ensure consistent, evidence-based communication in retail settings.
No takes yet. Share an insight, caveat, or question.
Wysota et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: